Wegovy (semaglutide 2.4mg) is the UK's most clinically established GLP-1 weight loss medication. But at prices ranging from £140 to £270 per month, it represents a significant financial commitment. Is it worth it? Let us look at the numbers honestly.
What Does Wegovy Actually Cost in the UK?
Pricing varies by dose (you titrate up over 5 months) and by provider. Here is a typical price breakdown:
| Dose | Who It's For | Typical UK price/month | |------|-------------|------------------------| | 0.25mg | Weeks 1-4 | £140–£160 | | 0.5mg | Weeks 5-8 | £155–£175 | | 1.0mg | Weeks 9-12 | £175–£200 | | 1.7mg | Weeks 13-16 | £200–£230 | | 2.4mg (maintenance) | Week 17+ | £220–£270 |
Patients typically pay the starter dose price for the first month, then increase as they titrate.
Which UK Providers Offer the Best Wegovy Price?
Most affordable options (2025):
- UK Meds — from £33.99 (per pen, so monthly cost depends on dose)
- Juniper UK — monthly plans from £65 (bundled programme)
- Second Nature — NHS-affiliated, competitive pricing with dietitian coaching included
- Voy — transparent monthly pricing with no hidden fees
- Boots Online Doctor — trusted but tends to sit at the higher end of the price range
Always compare the total monthly cost including any programme/membership fees, not just the medication price. Some providers advertise low medication costs but charge additional fees for consultations, dose reviews, or platform access.
Hidden Costs to Watch For
- Consultation fee — some providers charge £20–£50 per consultation (quarterly)
- Membership fee — a minority of providers charge a platform fee on top of medication cost
- Delivery fee — most reputable providers offer free delivery, but check the small print
- Cancellation policies — some plans lock you in for 3 months minimum
Is Wegovy Worth the Cost?
To answer this objectively, consider the alternatives and the outcomes:
Compared to obesity surgery: Bariatric surgery (gastric bypass or sleeve gastrectomy) costs £8,000–£15,000 privately in the UK. At £200/month for Wegovy, that is 40–75 months of medication — approximately 3–6 years. For many patients, Wegovy achieves comparable short-to-medium-term weight loss results without the surgical risks.
Compared to the cost of obesity: The UK HSJ estimates that obesity costs the average individual around £1,800–£3,200 per year in direct health expenditure (medications, GP visits, lost working days, mobility aids). Sustained weight loss through Wegovy reduces these downstream costs significantly.
Weight loss outcomes: In the STEP-1 trial, patients on Wegovy 2.4mg lost an average of 14.9% of their body weight — roughly 15kg for a 100kg person. That is a meaningful reduction in cardiovascular risk, blood pressure, sleep apnoea severity, and joint load.
Can You Get Help Paying for Wegovy?
- Employer benefits: Some UK employers with private health schemes are beginning to cover GLP-1 medications. Check your workplace benefits portal.
- Private health insurance: AXA, Bupa, and Vitality are beginning to cover GLP-1 medications in some policies — call your insurer.
- NHS: If you meet eligibility criteria and can wait, NHS access remains possible (see our NHS GLP-1 eligibility guide).
The Bottom Line on Wegovy Cost
£200/month is significant — roughly the cost of a gym membership plus a personal trainer. But the clinical outcomes from Wegovy are substantially stronger than either. For patients who have struggled with weight for years, with real metabolic consequences, it often represents excellent value.
Use the GLP-1 Directory to compare Wegovy providers across the UK and find the best current price.